Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, September 30, 2024
[ Mon, Sep 30th 2024
] - WOPRAI
Fri, September 27, 2024
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
Joseph Pantginis Reiterated (ATXS) at Strong Buy and Held Target at $16 on, Sep 27th, 2024
Joseph Pantginis of HC Wainwright & Co., Reiterated "Astria Therapeutics, Inc." (ATXS) at Strong Buy and Held Target at $16 on, Sep 27th, 2024.
Joseph has made no other calls on ATXS in the last 4 months.
There are 3 other peers that have a rating on ATXS. Out of the 3 peers that are also analyzing ATXS, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Joseph
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $26 on, Tuesday, August 13th, 2024
- Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $22 on, Tuesday, August 13th, 2024
- Stacy Ku of "TD Cowen" Initiated at Strong Buy and Held Target at $35 on, Monday, July 29th, 2024
